Related Experiment Video
Updated: May 6, 2026

Co-immunoprecipitation Assay Using Endogenous Nuclear Proteins from Cells Cultured Under Hypoxic Conditions
Published on: August 2, 2018
Oncogenic potential of Nrf2 and its principal target protein heme oxygenase-1
Hye-Kyung Na1, Young-Joon Surh2
1Department of Food & Nutrition, College of Human Ecology, Sungshin Women's University, Seoul 142-732, South Korea.
Abstract:
Nuclear factor erythroid 2-related factor 2 (Nrf2) is an essential component of cellular defense against a vast variety of endogenous and exogenous insults, including oxidative stress. Nrf2 acts as a master switch in the circuits upregulating the expression of various stress-response proteins, especially heme oxygenase-1 (HO-1). Paradoxically, however, recent studies have demonstrated oncogenic functions of Nrf2 and its major target protein HO-1. Levels of Nrf2 and HO-1 are elevated in many different types of human malignancies, which may facilitate the remodeling of the tumor microenvironment making it advantageous for the autonomic growth of cancer cells, metastasis, angiogenesis, and tolerance to chemotherapeutic agents and radiation and photodynamic therapy. In this context, the cellular stress response or cytoprotective signaling mediated via the Nrf2-HO-1 axis is hijacked by cancer cells for their growth advantage and survival of anticancer treatment. Therefore, Nrf2 and HO-1 may represent potential therapeutic targets in the management of cancer. This review highlights the roles of Nrf2 and HO-1 in proliferation of cancer cells, their tolerance/resistance to anticancer treatments, and metastasis or angiogenesis in tumor progression.
Insights
Nuclear factor erythroid 2-related factor 2 (Nrf2) and heme oxygenase-1 (HO-1) are crucial for cellular defense but are paradoxically hijacked by cancer. Elevated Nrf2 and HO-1 promote tumor growth, metastasis, and treatment resistance.
Area of Science:
- Molecular Biology
- Cellular Biology
- Oncology
Background:
- Nuclear factor erythroid 2-related factor 2 (Nrf2) is a key regulator of cellular defense against oxidative stress and various insults.
- Nrf2 orchestrates the expression of cytoprotective proteins, notably heme oxygenase-1 (HO-1).
- Recent evidence reveals oncogenic roles for both Nrf2 and HO-1 in cancer progression.
Purpose of the Study:
- To review the dual role of the Nrf2-HO-1 axis in cancer.
- To highlight how cancer cells exploit this pathway for growth and survival.
- To discuss Nrf2 and HO-1 as potential therapeutic targets in oncology.
Main Methods:
- Literature review of recent studies on Nrf2 and HO-1 in cancer.
- Analysis of the role of Nrf2-HO-1 in tumor microenvironment modulation.
- Examination of Nrf2-HO-1 involvement in cancer cell proliferation, metastasis, and treatment resistance.
Main Results:
- Elevated Nrf2 and HO-1 levels are observed in numerous human malignancies.
- The Nrf2-HO-1 pathway promotes cancer cell proliferation, angiogenesis, and metastasis.
- This axis confers resistance to chemotherapy, radiotherapy, and photodynamic therapy.
Conclusions:
- The cellular stress response mediated by Nrf2-HO-1 is co-opted by cancer cells for survival and proliferation.
- Targeting the Nrf2-HO-1 pathway presents a promising therapeutic strategy for cancer management.
- Further research into inhibiting Nrf2 and HO-1 could lead to novel cancer treatments.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes
NF-kB-dependent Signaling Pathway
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Regulation of Angiogenesis and Blood Supply

